Synthetic GH secretagogues inhibited (not stimulated) growth of human lung carcinoma cells expressing high levels of GHS receptors, suggesting an unexpected antiproliferative effect on cancer cells.
Growth INHIBITEDGH secretagogues actually suppressed lung cancer cell growth despite high receptor expression — the opposite of the feared pro-growth effect
What the researchers found
Synthetic peptidyl GH secretagogues inhibited proliferation of human CALU-1 lung carcinoma cells that express high levels of GHS receptors, demonstrating antiproliferative rather than growth-promoting activity in this cancer type.
Why it matters
The cancer biology community worried GH secretagogues might promote cancer growth. This study shows the opposite in lung cancer cells — they actually inhibit growth — which could change the safety assessment.
How the study worked
In-vitro study. GHS receptor binding characterized in human lung cancer tissues. CALU-1 lung cancer cell proliferation measured after treatment with hexarelin and other GH secretagogues.
What this study cannot tell us
Single cancer cell line. In-vitro proliferation inhibition may not translate to in-vivo tumor suppression. The mechanism of growth inhibition was not determined.
How to read the evidence
Preliminary in-vitro evidence from a single cell line with clear antiproliferative data, counterintuitively challenging pro-growth assumptions.
When this study was published
Published in 2002. GH secretagogue effects on cancer remain complex and tissue-dependent, with some cancers inhibited and others stimulated.
The bigger picture
Receptor activation doesn't always mean growth. In lung cancer cells, GHS-R activation suppresses growth — a finding that challenges assumptions about GH secretagogue cancer safety and opens potential anti-cancer applications.
Questions still open
- Do GH secretagogues inhibit growth of other cancer types?
- What mechanism converts GHS-R activation from proliferative to antiproliferative in cancer?
- Could GH secretagogues be repurposed as adjuvant cancer therapies?
Common questions
Do GH peptides cause cancer?
Could GH peptides treat cancer?
Read the original research
The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
Endocrinology, 143(2), 484-91
Citation
Ghè, Corrado; Cassoni, Paola; Catapano, Filomena; Marrocco, Tiziana; Deghenghi, Romano; Ghigo, Ezio; Muccioli, Giampiero; Papotti, Mauro. (2002). The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.. Endocrinology, 143(2), 484-91.